Announce Date | 06/18/2025 |
EPS Normalized Actual | $1.29 (Beat by $0.14) |
EPS GAAP Actual | $1.29 (Beat by $0.14) |
Revenue Actual | $1.3338B |
Revenue Surprise | Beat by $1333.8M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Apr 2028 | 8.53 | 12.77 | 8.21652 | 8.91028 | 1 |
Apr 2027 | 7.72 | 14.11 | 7.33116 | 8.0501 | -1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Apr 2025) | 0.68 | 0.68 | 1.3338B | -5.94% | 1333.8M |
FQ1 2025 (Jan 2025) | -2.83 | -2.83 | 1.26071B | 0.19% | 1260.71M |
FQ4 2024 (Oct 2024) | -1.45 | -1.45 | 1.47078B | 3.39% | 1470.78M |
FQ3 2024 (Jul 2024) | 1.45 | 1.45 | 1.44846B | 2.68% | 1448.46M |
FQ2 2024 (Apr 2024) | 1.42 | 1.42 | 1.41303B | 7.71% | 1413.03M |
FQ1 2024 (Jan 2024) | 1.28 | 1.28 | 1.25835B | 1.89% | 1258.35M |
FQ4 2023 (Oct 2023) | 2 | 2 | 1.42093B | -0.71% | 1420.93M |
FQ3 2023 (Jul 2023) | 2.13 | 2.13 | 1.4096B | 3.55% | 1409.6M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2028 (Jan 2028) | 1.66 | -- | 1.63533 | 1.71581 | 7 |
FQ4 2027 (Oct 2027) | 2.35 | -- | 2.31507 | 2.42901 | 5 |
FQ3 2027 (Jul 2027) | 2.57 | -- | 2.5318 | 2.65641 | 3 |
FQ1 2027 (Jan 2027) | 1.331 | -- | 1.31122 | 1.37575 | 5 |
FQ4 2026 (Oct 2026) | 2.18 | -- | 2.1622 | 2.19761 | 4 |
FQ3 2026 (Jul 2026) | 2.03 | -- | 2.01342 | 2.0464 | 3 |
FQ2 2026 (May 2026) | 2.234 | 69.56 | 2.234 | 2.234 | 2 |
FQ1 2026 (Jan 2026) | 1.8 | 257.22 | 1.74964 | 1.84508 | 3 |
FQ4 2025 (Oct 2025) | 2.53 | 157.31 | 2.46669 | 2.62109 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2028 (Jan 2028) | 1.33B | -- | 1.32B | 1.37B | 3 |
FQ4 2027 (Oct 2027) | 1.5B | -- | 1.48B | 1.54B | 6 |
FQ3 2027 (Jul 2027) | 1.55B | -- | 1.53B | 1.58B | 4 |
FQ1 2027 (Jan 2027) | 1.32B | -- | 1.3B | 1.35B | 4 |
FQ4 2026 (Oct 2026) | 1.47B | -- | 1.46B | 1.48B | 6 |
FQ3 2026 (Jul 2026) | 1.53B | -- | 1.52B | 1.54B | 4 |
FQ2 2026 (May 2026) | 1.54B | 13.54 | 1.54B | 1.54B | 2 |
FQ1 2026 (Jan 2026) | 1.43B | 11.83 | 1.4B | 1.46B | 4 |
FQ4 2025 (Oct 2025) | 1.39B | -5.81 | 1.36B | 1.43B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Apr 2025) | 0.68 | 0.68 | 100% | |
FQ1 2025 (Jan 2025) | -2.83 | -2.83 | 100% | |
FQ4 2024 (Oct 2024) | -1.45 | -1.45 | 100% | |
FQ3 2024 (Jul 2024) | 1.45 | 1.45 | 100% | |
FQ2 2024 (Apr 2024) | 1.42 | 1.42 | 100% | |
FQ1 2024 (Jan 2024) | 1.28 | 1.28 | 100% | |
FQ4 2023 (Oct 2023) | 2 | 2 | 100% | |
FQ3 2023 (Jul 2023) | 2.13 | 2.13 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Apr 2025) | $0B | $1.33B | $1333.8M | 100% |
FQ1 2025 (Jan 2025) | $0B | $1.26B | $1260.71M | 100% |
FQ4 2024 (Oct 2024) | $0B | $1.47B | $1470.78M | 100% |
FQ3 2024 (Jul 2024) | $0B | $1.45B | $1448.46M | 100% |
FQ2 2024 (Apr 2024) | $0B | $1.41B | $1413.03M | 100% |
FQ1 2024 (Jan 2024) | $0B | $1.26B | $1258.35M | 100% |
FQ4 2023 (Oct 2023) | $0B | $1.42B | $1420.93M | 100% |
FQ3 2023 (Jul 2023) | $0B | $1.41B | $1409.6M | 100% |